EUVIMEDEUVIMED entdecken
Crossref

Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ‐Mediated Immunotherapy

Yujie Luo iD, Chuanda Zhu iD, Xuefei Guo, Yunfei Xie, Yu Sun, Dan Lu, Yufei Xia, Zhiqiang Lin iD, Fuping You

Advanced Materials · 2025

DOI: 10.1002/adma.202419870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Yujie Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, NHC Key Laboratory of Medical Immunology, Department of Microbiolo…. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Interferon-beta, Calcium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University Clinical + X, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors have revolutionized cancer therapy; however, many patients exhibit suboptimal responses, which is due to inadequate T cell priming by the innate immune response. Metal ions play a critical role in modulating the innate immune response. However, the mechanisms by which metal ions facilitate dendritic cell maturation through the activation of interferon remain poorly understood. This research identifies a nanomaterial Calcium phosphate‐containing liposome (NanoCa), characterized by an atypical crystal structure and pH‐responsive profile. NanoCa promotes bone marrow‐derived dendritic cell maturation and exhibits antiviral effects and anti‐tumor properties in different tumor models. Also, NanoCa acts as an immunostimulant by fostering antibody production. Furthermore, when combined with programmed cell death 1 receptor (PD‐1) blocking antibodies, NanoCa synergistically enhances anti‐tumor efficacy in CT26 models. Mechanistically, NanoCa rapidly releases Ca 2+ via the lysosome pathway post‐endocytosis, subsequently triggering interferon through the Ca 2+ ‐calcineurin (CaN) ‐ nuclear factor of activated T cells 2 (NFATc2) ‐ protein kinase C beta (PKCβ) ‐ interferon regulatory factor 3 (IRF3) signal pathway. Single‐cell RNA sequencing (scRNA‐seq) shows NanoCa increases the population of tumoral infiltrating dendritic cell (DC), C1qc+ TAM, and CD8T_eff cells and decreases the CD8T_ex and immunosuppressive SPP1+ TAM population in tumor‐draining lymph nodes. Overall, NanoCa shows translational potential for anti‐tumor immune therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNanoparticlesInterferon-betaCalciumAnimalsMiceCalcium PhosphatesDendritic CellsHumansCell Line, TumorLiposomes

Stichwörter der Autor:innen

NanoCaantitumorimmune therapyinterferon

Substanzen

Calcium PhosphatesInterferon-betaCalciumcalcium phosphateLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, NHC Key Laboratory of Medical Immunology, Department of Microbiology & Infectious Disease Center, School of Basic Medical Science Peking…
  • Department of Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, P. R. China.
  • State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, P. R. China.

ORCID-Profile: Yujie Luo, Chuanda Zhu, Zhiqiang Lin

Förderung

  • National Natural Science Foundation of China
  • Peking University Clinical + X
  • National Key Research and Development Program of China
  • Beijing Natural Science Foundation
  • Distinguished Young Scholars Program
  • National Key Research and Major Program of the National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Luo, Y., Zhu, C., Guo, X., Xie, Y., Sun, Y., Lu, D., Xia, Y., Lin, Z., & You, F. (2025). Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ‐Mediated Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202419870

Vancouver

Luo Y, Zhu C, Guo X, Xie Y, Sun Y, Lu D, et al. Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ‐Mediated Immunotherapy. Advanced Materials. 2025. doi:10.1002/adma.202419870

BibTeX
@article{Luo2025,
  author = {Luo, Yujie and Zhu, Chuanda and Guo, Xuefei and Xie, Yunfei and Sun, Yu and Lu, Dan and Xia, Yufei and Lin, Zhiqiang and You, Fuping},
  title = {Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ‐Mediated Immunotherapy},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202419870}
}
Kostenlos starten →